Page last updated: 2024-08-22

aluminum sulfate and Enterovirus Infections

aluminum sulfate has been researched along with Enterovirus Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, JY; Chang, SC; Cheng, A; Chong, PC; Chou, AH; Fung, CP; Hsieh, SM; Hsieh, YC; Jiang, RH; Lin, YT; Liu, CC; Su, IJ; Tsai, HY1
Ai, X; Chen, QH; Chen, SG; Chen, XQ; Chen, YJ; Chu, K; Dong, YY; Gao, F; Ge, HM; Hu, YM; Ji, YG; Jin, H; Li, JX; Li, XL; Liang, YC; Liang, ZL; Liu, L; Liu, P; Luo, FJ; Mao, QY; Meng, FY; Shen, XL; Shi, NM; Tao, H; Wu, X; Yao, X; Zhang, Y; Zhang, YT; Zhang, ZY; Zhu, FC; Zhu, LW; Zhu, LY1

Trials

2 trial(s) available for aluminum sulfate and Enterovirus Infections

ArticleYear
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine.
    Vaccine, 2013, May-07, Volume: 31, Issue:20

    Topics: Adjuvants, Immunologic; Adult; Alum Compounds; Animals; Antibody Formation; Chlorocebus aethiops; Enterovirus; Enterovirus Infections; Female; Healthy Volunteers; Humans; Male; Middle Aged; Vaccination; Vaccines, Inactivated; Vero Cells; Viral Vaccines; Young Adult

2013
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet (London, England), 2013, Jun-08, Volume: 381, Issue:9882

    Topics: Adjuvants, Immunologic; Alum Compounds; Antibodies, Viral; Child, Preschool; Double-Blind Method; Enterovirus A, Human; Enterovirus Infections; Female; Humans; Immunity, Active; Infant; Kaplan-Meier Estimate; Male; Vaccines, Inactivated; Viral Vaccines

2013